Broker Notes: Why analysts name Cochlear, James Hardie and United Malt to buy now?

$Cochlear Ltd(COH.AU)$: Wilsons upgrades the stock to overweight from market-weight and raises the stock's target price 7.5% to A$235.00.
The Wilsons team says in a note that it is cautiously optimistic that primary referral volumes are recovering in the cochlear implant market, with electrode market leader Cochlear well-positioned to push the benefits of its tech.
Shares are 2.34% higher at A$216.95.

$James Hardie Industries PLC(JHX.AU)$: Morgan Stanley upgrades James Hardie to overweight from equal-weight while shaving 11% off his price target to A$51.00 for the stock.
While concerns around the impact of higher home-loan rates on demand for building materials are valid, Morgan Stanley analyst Andrew Scott thinks this is more than reflected in James Hardie's share price.
Shares are 2.67% higher at A$38.5.

$United Malt Group Ltd(UMG.AU)$: Bell Potter upgrades the stock to buy from hold with A$4.55 price target.
A normalization in Canadian crop conditions, stabilizing malt-barley spreads and delivery on recent capital investment initiatives are supportive of an improved FY 2023-2024 earnings base, Bell Potter says.
Shares are 0.51% higher at A$3.98.